Clinical Trials Directory

Trials / Unknown

UnknownNCT02837640

Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa

The Effect of L-Dopa on the Progression of Retinitis Pigmentosa

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Beirut Eye Specialist Hospital · Academic / Other
Sex
All
Age
10 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of L-Dopa on the progression of retinitis pigmentosa.

Detailed description

Retinitis pigmentosa is a group of progressive hereditary diseases that diffusely affects the functioning of photoreceptors and the pigment epithelium. It may be speculated that a protective effect on the pigment epithelium, as it is supposed for L-Dopa, can slow the progression of the disease or even lead to an, at least transient, improvement of visual functions. To evaluate the effect of L-Dopa on retinitis pigmentosa progression, visual acuity, electroretinogram and visual field will be preformed regularly.

Conditions

Interventions

TypeNameDescription
DRUGlevodopa-carbidopasinemet 200/50 1/2 tablet b.i.d. for 2 days and then t.i.d for 6 months

Timeline

Start date
2016-06-01
Primary completion
2017-06-01
Completion
2021-06-01
First posted
2016-07-19
Last updated
2016-07-19

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT02837640. Inclusion in this directory is not an endorsement.